<i>ZMYND11::MBTD1</i> Fusion in Myeloid/NK Cell Precursor Leukemia: A Case Report With Literature Review and Diagnostic Implications

Myeloid/NK cell precursor leukemia (MNKPL) is a rare, aggressive entity often misdiagnosed as acute myeloid leukemia (AML) or aggressive NK cell leukemia (ANKL) because of overlapping markers (CD7<sup>+</sup>, CD13/CD33<sup>+</sup>, CD56<sup>+</sup>, myeloperoxidase [MPO]-). We report a patient initially diagnosed with ANKL; subsequent flow-cytometric reevaluation (CD7<sup>+</sup>, CD13<sup>+</sup>, CD33<sup>+</sup>, CD34<sup>+</sup>, CD56<sup>+</sup>, CD117<sup>+</sup>, MPO<sup>-</sup>) supported a diagnosis of MNKPL. RNA sequencing and nested PCR identified an in-frame ZMYND11::MBTD1 fusion. A review of published ZMYND11::MBTD1 leukemias (n = 5) found immunophenotypes highly consistent with MNKPL, suggesting prior misclassification. These findings support ZMYND11::MBTD1 as a recurrent lesion in MNKPL and a practical aid to diagnosis and treatment selection.

Authors

Institutions

Publication Details

Journal
Pediatric Blood & Cancer
Published
2025-12-27
DOI
https://doi.org/10.1002/1545-5017.70044
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ZMYND11::MBTD1 Fusion in Myeloid/NK Cell Precursor Leukemia: A Case Report With Literature Review and Diagnostic Implications

Shaoyan Hu, Shengbin Zhao, Xin Su, Shengqin Cheng et al.
Pediatric Blood & Cancer
Acute Myeloid Leukemia Research
article

ZMYND11::MBTD1 Fusion in Myeloid/NK Cell Precursor Leukemia: A Case Report With Literature Review and Diagnostic Implications

Shaoyan Hu, Shengbin Zhao, Xin Su, Shengqin Cheng, Hao Liang, Zhizhuo Du, Ping Chen, Li Gao, Peifang Xiao, Jie Miao
article en

Abstract

Myeloid/NK cell precursor leukemia (MNKPL) is a rare, aggressive entity often misdiagnosed as acute myeloid leukemia (AML) or aggressive NK cell leukemia (ANKL) because of overlapping markers (CD7<sup>+</sup>, CD13/CD33<sup>+</sup>, CD56<sup>+</sup>, myeloperoxidase [MPO]-). We report a patient initially diagnosed with ANKL; subsequent flow-cytometric reevaluation (CD7<sup>+</sup>, CD13<sup>+</sup>, CD33<sup>+</sup>, CD34<sup>+</sup>, CD56<sup>+</sup>, CD117<sup>+</sup>, MPO<sup>-</sup>) supported a diagnosis of MNKPL. RNA sequencing and nested PCR identified an in-frame ZMYND11::MBTD1 fusion. A review of published ZMYND11::MBTD1 leukemias (n = 5) found immunophenotypes highly consistent with MNKPL, suggesting prior misclassification. These findings support ZMYND11::MBTD1 as a recurrent lesion in MNKPL and a practical aid to diagnosis and treatment selection.

Pediatric Blood & CancerVol. 73(2)
Soochow University (CN), Suzhou Vocational Health College (CN)
Brigham and Women's Hospital, Jiangsu Commission of Health, Soochow University
Openalex Percentile: Top 24%
Acute Myeloid Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.